Please be advised that all of the CDC-sponsored EUAs listed on this website are currently in effect and will remain in effect through June 23, 2010, unless the declaration of emergency is terminated or the Emergency Use Authorizations are revoked sooner or the declaration of emergency is extended. Additional information and guidance regarding EUA termination will be posted on this website closer to the eventual termination date.

Emergency Use Authorization of Peramivir IV

FDA-Issued Peramivir IV EUA Letter

Fact Sheet for Health Care Providers 

• FDA Questions and Answers for Health Care Providers: Renal Dosing and Administration Recommendations for Peramivir IV
• Peramivir IV Questions and Answers for Health Care Providers
• To request Peramivir IV (licensed clinicians with prescribing privileges ONLY), CLICK HERE. For any questions, call 1-800-CDC-INFO (1-800-232-4636).
• For questions relating to this Emergency Use Authorization, contact: EUA.OCET@fda.hhs.gov

Fact Sheet for Patients and Parents/Caregivers

• Fact Sheet for Patients and Parents/Caregivers (Spanish)

Intravenous Peramivir

Mandatory Requirements for Reporting all Medication Errors and selected Adverse Events regarding emergency use of Peramivir IV

• For detailed information, please refer to the Peramivir IV Fact Sheet for Health Care Providers. For additional information, please refer to Information for Healthcare Professionals: Mandatory Adverse Event Reporting for Emergency Use of Peramivir Under EUA.